Germinalinine
Internal ID | 39d87f15-c792-42ee-ad76-e1cf4cf7253a |
Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal alkaloids > Cerveratrum-type alkaloids |
IUPAC Name | [(1S,2S,6S,9S,11R,12R,13S,14S,15S,16R,18S,19S,22S,23S,25R)-16-acetyloxy-10,12,14,23-tetrahydroxy-6,10,19-trimethyl-13-[(2R)-2-methylbutanoyl]oxy-24-oxa-4-azaheptacyclo[12.12.0.02,11.04,9.015,25.018,23.019,25]hexacosan-22-yl] (2R,3R)-2,3-dihydroxy-2-methylbutanoate |
SMILES (Canonical) | CCC(C)C(=O)OC1C(C2C(CN3CC(CCC3C2(C)O)C)C4C1(C5C(CC6C7(C5(C4)OC6(C(CC7)OC(=O)C(C)(C(C)O)O)O)C)OC(=O)C)O)O |
SMILES (Isomeric) | CC[C@@H](C)C(=O)O[C@H]1[C@@H]([C@H]2[C@@H](CN3C[C@H](CC[C@H]3C2(C)O)C)[C@H]4[C@@]1([C@@H]5[C@@H](C[C@H]6[C@]7([C@]5(C4)O[C@@]6([C@H](CC7)OC(=O)[C@@](C)([C@@H](C)O)O)O)C)OC(=O)C)O)O |
InChI | InChI=1S/C39H61NO13/c1-9-19(3)32(44)52-31-29(43)28-22(17-40-16-18(2)10-11-26(40)36(28,8)47)23-15-37-30(38(23,31)48)24(50-21(5)42)14-25-34(37,6)13-12-27(39(25,49)53-37)51-33(45)35(7,46)20(4)41/h18-20,22-31,41,43,46-49H,9-17H2,1-8H3/t18-,19+,20+,22-,23-,24+,25-,26-,27-,28+,29+,30+,31-,34-,35+,36?,37+,38-,39-/m0/s1 |
InChI Key | MPAXORVZKLDHRC-PCRQMNHYSA-N |
Popularity | 2 references in papers |
Molecular Formula | C39H61NO13 |
Molecular Weight | 751.90 g/mol |
Exact Mass | 751.41429100 g/mol |
Topological Polar Surface Area (TPSA) | 213.00 Ų |
XlogP | 1.40 |
Atomic LogP (AlogP) | 1.04 |
H-Bond Acceptor | 14 |
H-Bond Donor | 6 |
Rotatable Bonds | 7 |
58162-51-9 |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | - | 0.6249 | 62.49% |
Caco-2 | - | 0.8690 | 86.90% |
Blood Brain Barrier | - | 0.5250 | 52.50% |
Human oral bioavailability | - | 0.6714 | 67.14% |
Subcellular localzation | Lysosomes | 0.4928 | 49.28% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.9136 | 91.36% |
OATP1B3 inhibitior | + | 0.9479 | 94.79% |
MATE1 inhibitior | - | 0.9000 | 90.00% |
OCT2 inhibitior | - | 0.7250 | 72.50% |
BSEP inhibitior | + | 0.6568 | 65.68% |
P-glycoprotein inhibitior | + | 0.7589 | 75.89% |
P-glycoprotein substrate | + | 0.7281 | 72.81% |
CYP3A4 substrate | + | 0.7463 | 74.63% |
CYP2C9 substrate | - | 1.0000 | 100.00% |
CYP2D6 substrate | - | 0.8018 | 80.18% |
CYP3A4 inhibition | - | 0.8619 | 86.19% |
CYP2C9 inhibition | - | 0.8971 | 89.71% |
CYP2C19 inhibition | - | 0.9009 | 90.09% |
CYP2D6 inhibition | - | 0.9316 | 93.16% |
CYP1A2 inhibition | - | 0.9222 | 92.22% |
CYP2C8 inhibition | + | 0.7490 | 74.90% |
CYP inhibitory promiscuity | - | 0.9592 | 95.92% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.9800 | 98.00% |
Carcinogenicity (trinary) | Non-required | 0.5268 | 52.68% |
Eye corrosion | - | 0.9886 | 98.86% |
Eye irritation | - | 0.9128 | 91.28% |
Skin irritation | - | 0.7652 | 76.52% |
Skin corrosion | - | 0.9327 | 93.27% |
Ames mutagenesis | - | 0.6211 | 62.11% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.3895 | 38.95% |
Micronuclear | + | 0.5900 | 59.00% |
Hepatotoxicity | + | 0.5072 | 50.72% |
skin sensitisation | - | 0.8819 | 88.19% |
Respiratory toxicity | + | 0.6444 | 64.44% |
Reproductive toxicity | + | 0.8667 | 86.67% |
Mitochondrial toxicity | + | 0.9625 | 96.25% |
Nephrotoxicity | + | 0.5448 | 54.48% |
Acute Oral Toxicity (c) | I | 0.6759 | 67.59% |
Estrogen receptor binding | + | 0.7207 | 72.07% |
Androgen receptor binding | + | 0.7556 | 75.56% |
Thyroid receptor binding | - | 0.5779 | 57.79% |
Glucocorticoid receptor binding | + | 0.7415 | 74.15% |
Aromatase binding | + | 0.6759 | 67.59% |
PPAR gamma | + | 0.7536 | 75.36% |
Honey bee toxicity | - | 0.6537 | 65.37% |
Biodegradation | - | 0.8000 | 80.00% |
Crustacea aquatic toxicity | - | 0.5500 | 55.00% |
Fish aquatic toxicity | + | 0.8107 | 81.07% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 99.95% | 97.25% |
CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 99.45% | 85.14% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.24% | 96.09% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 97.25% | 96.77% |
CHEMBL2581 | P07339 | Cathepsin D | 96.65% | 98.95% |
CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 95.38% | 89.05% |
CHEMBL1914 | P06276 | Butyrylcholinesterase | 94.45% | 95.00% |
CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 94.15% | 97.14% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.92% | 94.45% |
CHEMBL2996 | Q05655 | Protein kinase C delta | 93.07% | 97.79% |
CHEMBL299 | P17252 | Protein kinase C alpha | 92.42% | 98.03% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 92.38% | 95.89% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 91.95% | 86.33% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 91.42% | 100.00% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 91.31% | 82.50% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.11% | 97.09% |
CHEMBL3922 | P50579 | Methionine aminopeptidase 2 | 90.76% | 97.28% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 90.59% | 82.69% |
CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 90.17% | 89.50% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 89.19% | 100.00% |
CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 89.18% | 99.17% |
CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 88.77% | 95.36% |
CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 88.75% | 91.03% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.62% | 96.47% |
CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 87.20% | 100.00% |
CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 86.96% | 99.00% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.74% | 93.56% |
CHEMBL5600 | P27448 | Serine/threonine-protein kinase c-TAK1 | 85.70% | 88.81% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.38% | 100.00% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.70% | 95.89% |
CHEMBL2094135 | Q96BI3 | Gamma-secretase | 84.68% | 98.05% |
CHEMBL3045 | P05771 | Protein kinase C beta | 84.55% | 97.63% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 84.52% | 96.90% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 84.15% | 94.00% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 83.76% | 92.50% |
CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 83.59% | 97.29% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 82.54% | 97.50% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 82.49% | 95.38% |
CHEMBL2373 | P21730 | C5a anaphylatoxin chemotactic receptor | 82.44% | 92.62% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.40% | 95.50% |
CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 82.26% | 92.88% |
CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 81.99% | 97.56% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 81.30% | 91.11% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 81.17% | 96.61% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 80.79% | 98.75% |
CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 80.69% | 90.93% |
CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 80.50% | 95.27% |
CHEMBL1821 | P08173 | Muscarinic acetylcholine receptor M4 | 80.48% | 94.08% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Veratrum album |
Veratrum nigrum |
PubChem | 101286251 |
NPASS | NPC70245 |
LOTUS | LTS0201852 |
wikiData | Q105169297 |